Sullivan Taylor, Rogalska Anna, Vargas Leticia
Obstetrics and Gynecology, University of the Incarnate Word School of Osteopathic Medicine, San Antonio, USA.
Obstetrics and Gynecology, Metropolitan Hospital, San Antonio, USA.
Cureus. 2020 Sep 29;12(9):e10720. doi: 10.7759/cureus.10720.
Atrioventricular (AV) block in pregnancy is infrequently encountered and there is little management guidance available. We present a case of a 24-year-old G3P1011 at 24 weeks' gestation who presented to the obstetrics and gynecology clinic complaining of palpitations, fatigue, and dyspnea on exertion. Cardiology workup including an electrocardiogram (ECG) and Holter monitor detected second-degree type II (Mobitz) AV block with the longest asystole event lasting 15.8 seconds. A St. Jude's dual-chamber pacemaker (Abbott Laboratories, Abbott Park, IL) was implanted immediately. Standard radiation precautions were taken with additional shielding for the fetus. The patient experienced significant improvement in her symptoms. The patient went into labor at 37 3/7 weeks. Due to non-reassuring fetal heart tones, a cesarean section was performed, and a healthy baby girl was born. The management of heart block in pregnancy can be divided into involving those who are symptomatic and those who are asymptomatic. Symptoms of heart block can include palpitations, fatigue, dyspnea, and/or syncope; the presence of these symptoms warrants the placement of a pacemaker, preferably during pre-pregnancy or during the first two trimesters, as high-grade heart block is associated with significant mortality. Those who are in their last trimester or postpartum should consider the use of a temporary pacemaker as heart block could be due to pregnancy-related cardiovascular changes. For women with heart block, labor and delivery could result in worsening of bradycardia due to uterine contractions displacing blood into the central circulation. Most women with heart block do well in labor and delivery and having a pacemaker is not necessarily an indication for a cesarean section.
妊娠期房室传导阻滞较为罕见,且几乎没有可用的管理指南。我们报告一例24岁、孕3产1(G3P1011)、妊娠24周的孕妇,她因心悸、疲劳和劳力性呼吸困难就诊于妇产科门诊。包括心电图(ECG)和动态心电图监测在内的心脏检查发现二度II型(莫氏)房室传导阻滞,最长停搏事件持续15.8秒。立即植入了圣犹达双腔起搏器(雅培实验室,伊利诺伊州雅培公园)。采取了标准的辐射防护措施,并对胎儿进行了额外的屏蔽。患者症状有显著改善。患者在37 3/7周时临产。由于胎儿心率不令人放心,进行了剖宫产,娩出一名健康女婴。妊娠期心脏传导阻滞的管理可分为有症状者和无症状者。心脏传导阻滞的症状可包括心悸、疲劳、呼吸困难和/或晕厥;出现这些症状需要植入起搏器,最好在孕前或孕早期,因为高度心脏传导阻滞与显著的死亡率相关。处于妊娠晚期或产后的患者应考虑使用临时起搏器,因为心脏传导阻滞可能与妊娠相关的心血管变化有关。对于患有心脏传导阻滞的女性,分娩过程中子宫收缩将血液挤入体循环可能导致心动过缓加重。大多数患有心脏传导阻滞的女性在分娩过程中情况良好,有起搏器不一定是剖宫产的指征。